Search Results for

Cirrhosis Management Prevention in Futures

Progress in the hepatic cirrhosis prevention and management of cirrhosis continues. Research is underway to determine the mechanism of scar formation in the liver and how the healing process can be halted or even reversed. The newest and best treatments for viral diseases of the liver are being developed to prevent progression to cirrhosis. Prevention of viral hepatitis by vaccination, which is available for hepatitis B, is in development for hepatitis C. The treatment of complications of cirrhosis are continuously developed and tested. Finally, the research aims to identify new proteins in the blood can detect liver cancer early or predict which patients will develop liver cancer.

Hepatic Cirrhosis Disease Brief Information

• Cirrhosis disease is a liver complication disease leading to loss of liver cells and irreversible scarring of the liver.
• Alcohol and viral hepatitis C and hepatitis C are common causes of cirrhosis, although there are many other causes.
• Cirrhosis can cause bruising, weakness, loss of appetite, yellowing of the skin (jaundice), fatigue and itching.
• The cirrhosis diagnosis can be suggested by history, blood tests and physical examination, and can be confirmed by liver biopsy.
• The complications of liver cirrhosis are edema and ascites, variceal bleeding, spontaneous bacterial peritonitis, hepatic encephalopathy, hypersplenism, hepatorenal syndrome, Hepatopulmonary syndrome and liver cancer.
• Treatment of cirrhosis is designed to prevent more damage to the liver, treatment of complications of cirrhosis, and prevention or early detection of liver cancer.
• Liver transplantation is becoming an important option for treating patients with advanced cirrhosis.

Incoming Search Terms :

Usually Signs of Hepatitis A Symptoms

The Hepatitis A symptoms and signs usually appear from 15 to 50 days (2 to 7 weeks) after exposure to hepatitis A virus (HAV), and the average time HAV symptoms appears is 4 weeks. The hepatitis A symptoms and signs are usually mild and can not be observed in children under 6 years. Among older children and adults, early symptoms are similar to those of a stomach virus.

Possible hepatitis A symptoms and signs include:
- Extreme fatigue (tiredness).
- Fever.
- Sore muscles.
- Headaches.
- Pain in the right side of the abdomen below the ribs (when the liver is located).
- Nausea.
- Loss of appetite and weight loss.
- Yellowing of the skin and whites of the eyes (jaundice), sometimes accompanied by dark urine and clay-colored (whitish) stools. Jaundice is less common in children and young adults.

About 15% of people with signs of hepatitis A have symptoms of infection with HAV that performance or the last 6 to 9 months after the first infection occurred.1 The infection of hepatitis A is usually more severe than the first time, but the Arthritis can occur with it. After the infection goes away, the person usually returns to normal health. Rarely, cholestatic hepatitis occurs, which can cause itching and can last throughout the infection.

In general, when signs of hepatitis A symptoms occur, the amount of virus is shed in the feces is in decline. You can still spread the virus, but is less likely to do so after symptoms appear. The symptoms of hepatitis A signs usually last less than 2 months. In other countries, hepatitis A also called as l’hépatite A, la hepatitis A, epatite A, WZW typu A, hepatitt A.

Incoming Search Terms :

Considerations For The Vaccine Against Hepatitis A

Adults who are considering a trip abroad where hepatitis A is common may in to test for antibodies to HAV (anti-HAV test) before starting a vaccination program against hepatitis A. If you already have HAV in the blood, which are protected against infection, and should not be vaccinated.

Please consider the following before you go through tests with anti-HAV before vaccination:

• The schedule can be less expensive than anti-HAV testing. The testing costs include the cost of a physician visit and laboratory tests. If tests show that you need to get vaccinated, you must pay to complete the vaccination series (two shots given at different times), including costs of additional consultations.
• You can receive the vaccine against hepatitis A, even if you have antibodies against hepatitis A in the blood, and no harm would result.
• The vaccine against hepatitis A is not fully effective until 4 weeks after injection. But the vaccine will provide some protection after 2 weeks.

If you will be tested for anti-HAV, make sure to do before your trip. People over 60 who want to receive the vaccine before 4 weeks before departure, because evidence suggests that the immune response develops more slowly in older people.

If you find that you need the vaccine, but which moves at less than 4 weeks, you should receive the first shot in the vaccination. One shot provides protection to 90% by the disease and may reduce the severity of the disease. If you want to be extra careful, you may receive the first shot in the vaccination and the injection of immune globulin (IG). This will ensure you’re protected against HAV. You can receive the second injection of the vaccine against hepatitis A 6 to 18 months (as recommended by the manufacturer of the vaccine) after the first shooting.

Other factors to consider regarding the vaccine against Hepatitis A :

• Two doses of vaccine are needed to protect themselves better, so try to get his first shot at least 6 months before going to a foreign country where hepatitis A is common.
• Routine vaccination of hospital personnel, food handlers and child care workers and attendees Center does not occur at this time, since their probability of infection is generally higher than the general community. However, some centers have child care workers get the shot because it works so well to prevent the disease. There are also very low likelihood of vaccine side effects. If outbreaks of HAV infection occur in these environments, people who have been exposed to the virus should receive an injection of immunoglobulin (IG).
• If you have had close personal contact with someone who has hepatitis A, you should get the vaccine against hepatitis A or an injection of IG as soon as possible. If you have received vaccine or IG within 2 weeks of exposure to hepatitis, you may not have symptoms of infection with HAV. For more information, see the section on drugs in this matter.
• The vaccine against hepatitis A also provides some protection against infection if exposed to the virus.

Incoming Search Terms :

Prevention of Hepatitis A Using Vaccine

The vaccine against hepatitis A (Hepatitis A Vaccine) is the most effective means of preventing infection of hepatitis A virus (HAV). The hepatitis A vaccines provides 94% to 100% protection if you have two shots of vaccine.

Immunization with the hepatitis A vaccine against hepatitis A is recommended for:
- All children from age 1. Two separate doses are given at least 6 months apart. The United States Centers for Disease Control and Prevention made this recommendation in 2006. Many children and adolescents have not had the hepatitis A vaccine.
- Adolescents and children who have not had the vaccine against hepatitis A and are in the following situations:

• An epidemic of the disease has occurred recently.
• They live in a community or state that has established routine immunization because the disease occurs more frequently than in other areas.

- People with health travel, work or lifestyle puts them at risk of exposure. This includes:

• Those planning a trip to a foreign country where sanitary conditions are poor and hepatitis A is common.
• People who use illegal drugs.
• Men who have sex with men.
• People who work with monkeys that are infected and those who work with the virus in a research context.
• People with long-term (chronic) liver disease.
• Who are awaiting or have undergone a liver transplant.
• Persons with hemophilia or related disorders in blood clotting.

A combination hepatitis vaccine (Twinrix vaccine) that prevents hepatitis B and hepatitis A is available for persons over 18 years.

Incoming Search Terms :

Cirrhosis Diagnosis and Evaluation Methods

The best test for the diagnosis of cirrhosis is a liver biopsy. Liver biopsies on cirrhosis diagnosis, however, has a low risk of serious complications and, therefore, biopsy is usually reserved for patients in whom the diagnosis of the type of disease or the presence of liver cirrhosis is unclear. The possibility that cirrhosis can be suggested by history, physical examination or routine tests. If cirrhosis is present, other tests may be used to determine the severity of cirrhosis and presence of complications. The tests also can be used to diagnose the underlying disease causes cirrhosis. Here are some examples of how doctors learn to diagnose and assess cirrhosis :

• Taking the history of the patient, the doctor may discover a history of prolonged and excessive consumption of alcohol, a history of intravenous drug abuse, or history of hepatitis. This information suggests the possibility of liver disease and cirrhosis.
• Patients who are known to have chronic viral hepatitis B or C are more likely to have cirrhosis.
• Some patients had cirrhosis of liver hypertrophy and / or spleen. A doctor can often feel (palpate) the lower edge of an enlarged liver below the right rib cage and feel the tip of the spleen in the left ribcage. A cirrhotic liver also feels firmer and more irregular than normal liver.
• Auto-antibodies (antinuclear antibodies, anti-smooth muscle antibodies and anti-mitochondria) are sometimes detected in the blood and can be a sign of the presence of autoimmune hepatitis or primary biliary cirrhosis, both can lead to cirrhosis.
• Liver cancer (hepatocellular carcinoma) can be detected by CT and MRI or ultrasound of the abdomen. Liver cancer occurs more frequently in individuals with underlying cirrhosis.
• Some patients with cirrhosis, alcoholic cirrhosis, especially, have small red spider-like markings (telangiectasias) on the skin, especially in the chest, consisting of enlarged blood vessels radiate. These spider telangiectasias can be observed in individuals without liver disease, however.
• Patients with abnormal deposits of copper in the eye or certain types of neurological May has Wilson’s disease, a genetic disease in which there is manipulation and abnormal accumulation of copper in the body like the liver, which can lead to cirrhosis.
• May is unexpectedly esophageal varices during upper endoscopy (EGD), suggesting cirrhosis.
• Computed Tomography (CT or CAT) or magnetic resonance imaging (MRI) and ultrasound examinations of the abdomen done for reasons other than to evaluate the possibility of liver disease in May unexpectedly detect abnormal liver hypertrophy nodular liver, enlarged spleen, and fluid in the abdomen suggest cirrhosis.
• Jaundice (yellowing of the skin and whites of the eyes due to elevated levels of bilirubin in the blood) is common in patients with cirrhosis, but jaundice can occur in patients suffering from liver cirrhosis and other conditions such as hemolysis (excess red blood cells break down).
• Swelling of the abdomen (ascites) and / or legs (edema) due to fluid retention is common in patients with cirrhosis of many other illnesses can make routinely, for example, congestive heart failure.
• The advanced cirrhosis leads to a lower level of albumin in the blood and reduces clotting factors due to the loss of the ability of the liver to produce these proteins. Therefore, the decreased levels of albumin in the blood suggest cirrhosis or abnormal bleeding.
• Abnormal elevation of liver enzymes in the blood (such as ALT and AST), which are regularly supplied as part of annual health examinations suggest that inflammation or liver damage from many causes, and cirrhosis.
• Patients with high levels of iron in the blood may have hemochromatosis, a genetic disease of the liver in which iron is handled in an abnormal way, leading to cirrhosis.
• If there is an accumulation of fluid in the abdomen, a fluid sample can be removed using a long needle. The liquid may be inspected and tested. Test results may suggest the presence of cirrhosis as the cause of the fluid.

Incoming Search Terms :